Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.
The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.
As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.
The journal does not accept study protocols, animal-based or cell line-based studies.
《Therapeutics And Clinical Risk Management》是一本由Dove Medical Press Ltd.出版商出版的專業醫學期刊,該刊創刊于2005年,刊期1 issue/year,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 4區,小類學科:衛生保健與服務 4區;在JCR(Journal Citation Reports)分區等級為Q3。該刊發文范圍涵蓋衛生保健與服務等領域,旨在及時、準確、全面地報道國內外衛生保健與服務工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為2.755,平均審稿速度16 Weeks。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
醫學 | 4區 | HEALTH CARE SCIENCES & SERVICES 衛生保健與服務 | 4區 | 否 | 否 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q3 | HEALTH CARE SCIENCES & SERVICES | Q3 | 2.755 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
2.755 | 43 | 96.77% | 78.40% | 開放 | 16 Weeks |